Related Experiment Videos
Congenital myasthenic syndromes
Joern P Sieb1, Simone Kraner, Ortrud K Steinlein
1Department of Neurology, Max Planck Institute of Psychiatry, Munich, Germany.
Seminars in Pediatric Neurology
|July 26, 2002
Summary
Congenital myasthenic syndromes (CMS) are inherited neuromuscular disorders affecting neuromuscular transmission. Genetic mutations in acetylcholine receptor (AChR) subunits and related proteins cause diverse CMS subtypes with varying acetylcholine responses.
Area of Science:
- Neurology
- Genetics
- Molecular Biology
Background:
- Congenital myasthenic syndromes (CMS) represent a group of inherited disorders impacting neuromuscular transmission.
- Diagnosis involves fatigable weakness, decremental EMG, and negative acetylcholine receptor (AChR) antibodies.
- Recent advancements have significantly improved the understanding of CMS's molecular underpinnings.
Purpose of the Study:
- To review the molecular basis of congenital myasthenic syndromes.
- To elucidate the mechanisms by which genetic mutations affect neuromuscular transmission in CMS.
- To categorize CMS based on altered acetylcholine receptor function and enzyme deficiencies.
Main Methods:
- Analysis of mutations in acetylcholine receptor (AChR) subunit genes.
- Investigation of mutations in acetylcholinesterase and choline acetyltransferase genes.
- Correlation of genotype with clinical phenotypes and neuromuscular transmission defects.
Main Results:
- Numerous disease-associated mutations in AChR subunits have been identified.
- Mutations lead to decreased AChR function in fast-channel syndromes and primary AChR deficiency.
- Increased AChR function is observed in slow-channel CMS due to prolonged channel opening.
- Deficiencies in acetylcholinesterase and choline acetyltransferase are linked to specific CMS forms, including those with episodic apnea.
Conclusions:
- Genetic mutations are the primary cause of congenital myasthenic syndromes.
- Understanding these mutations clarifies the diverse mechanisms of neuromuscular transmission failure in CMS.
- Molecular diagnosis is crucial for classifying CMS subtypes and guiding potential therapeutic strategies.